The following teams of clients with cardiovascular disease were not A part of clinical security and efficacy trials for CIALIS, and for that reason until further data is available, CIALIS isn't proposed for the following groups of individuals:The dose may be improved to 20 mg or lowered to five mg, based upon particular person efficacy and tolerabi